Na ọnụnọ nke 2.8 mM D-glucose, beta-D-glucose pentaacetate (1. 7 mmM) agbakwunyere insulin ntọhapụ sitere na agwaetiti pancreatic dịpụrụ adịpụ karịa alfa-D-glucose pentaacetate.N'otu aka ahụ, mmụba n'ihu na mmepụta insulin nke nateglinide (0.01 mM) kpalitere dị elu na agwaetiti ndị ekpughere na beta-karia alfa-D-glucose pentaacetate.N'aka nke ọzọ, na ọnụnọ 2.8 mmM D-glucose na-enweghị isi, alfa-L-glucose pentaacetate, mana ọ bụghị beta-L-glucose pentaacetate, na-abawanye mmepụta insulin nke ukwuu.Ike insulinotropic dị elu nke beta-anomer nke D-glucose pentaacetate dabara n'eziokwu na ọ na-abawanye ụbara ọnụ n'etiti D-[U-14C]glucose oxidation na D-[5-3H] glucose itinye n'ọrụ, ebe alfa-D. -glucose pentaacetate emeghị otú ahụ.A na-atụgharị nchoputa ndị a iji kwado echiche ahụ na mkpali nke ntọhapụ insulin site na esters ndị a bụ nke sitere na mmekọrịta ha na onye na-anabata stereospecific, na-ahọrọ maka nhazi nke C1 na-ahụkarị na beta-D-glucose pentaacetate na alpha-L- glucose pentaacetate.
